15 imzalar
Koleksiyon tamamlandı
Bu bir çevrimiçi dilekçedir Avrupa Parlamentosu .
Dilekçe şu adrese gönderiliyor: Petitionsausschuss des Europäischen Parlaments
The petitioner claims that the medicinal product Dotarem (a gadolinium-based contrast imaging agent), which is marketed in the European Union and used during medical examination procedures with Magnetic Resonance Imaging (MRI), caused him serious toxic poisoning. In particular, he claims that the medication was not removed by the kidneys within one week, as indicated on the medication’s instructions, and that 3.5 months after he was administered the medication, it was diagnosed that the amount of gadolinium that exits from his urine is three times the maximum acceptable limit. He also claims that, as a result, he developed systemic fibrosis throughout his body with obvious damage to the skin, eyes, face, and severe physical exhaustion. He calls for all the necessary measures to be taken to ensure the public health of EU citizens and for him to be compensated by the Dotarem manufacturer and to be admitted in a specialized EU clinic for the removal of the gadolinium from his body.
Dilekçeye bağlantı
QR kodlu yırtma fişi
indir (PDF)Dilekçe detayları
Dilekçe başlatıldı:
24.09.2019
Dilekçe biter:
23.09.2020
Bölge :
Avrupa Birliği
Konu:
Sağlık
Bu kampanya aşağıdaki dillere çevrilmiştir:
tartışma
The same happened to me, 3 month after the contrast administration, my 24hour urine contained 8.244mcg gadolinium per gram creatinine instead of the normal max 0.019mcg. i am having terrible debilitating symptoms.
Henüz KARŞI argüman yok.